{"id": "1360642501028311044", "creation": 1613237426.0, "user_id": "1247376635004936192", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) #COVID19 #vaccine against the B.1.351 variant in #SouthAfrica \n\nA two-dose regimen of ChAdOx1-nCoV19 #oxfordvaccine  did not show protection against mild-moderate #COVID-19 due to B.1.351 variant.\nhttps://t.co/rJQthQVdG7 https://t.co/PlaFqJSfuA", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#SOUTHAFRICA", "#OXFORDVACCINE", "#COVID"]}